Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.49 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 6/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | SIRT2 | Q8IXJ6 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29534108 | 0.94 | TDP1 (0.42) | TDP1PAX8NPSR1MAPTMEN1 | |
| SCHEMBL12994492 | 0.88 | SIRT2 (0.41) | TDP1PAX8NPSR1MAPTSIRT2 | |
| SCHEMBL29702317 | 0.84 | SIRT2 (0.42) | TDP1PAX8NPSR1MAPTSIRT2 | |
| Hydrochloric Acid SCHEMBL31450109 | 0.83 | MDM2 (0.44) | TDP1PAX8NPSR1MAPTMEN1 | |
| SCHEMBL1755615 | 0.81 | TDP1 (0.61) | TDP1PAX8NPSR1MAPTMEN1 | |
| SCHEMBL29702316 | 0.81 | SIRT2 (0.39) | TDP1PAX8SIRT2 | |
| SCHEMBL31450152 | 0.81 | TLR2 (0.42) | TDP1PAX8NPSR1MAPTMEN1 | |
| SCHEMBL7368138 | 0.80 | SIRT2 (0.51) | SIRT2 | |
| SCHEMBL17859348 | 0.80 | SIRT2 (0.51) | SIRT2 | |
| SCHEMBL29702381 | 0.79 | MDM2 (0.49) | KMT2ASIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119661633-A | Method for full liquid phase synthesis of blue copper peptide | 湖南益安生物科技有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119638822-A | Full liquid phase synthesis method of oligopeptide-1 | 湖南益安生物科技有限公司 | 2025-03-18 | — | — | CN | disclosed |